PTGS2 and lung carcinoma: It should also be noted that COX-2 expression increases in patient treated by taxanes (Subbaramaiah et al, 2003; Altorki et al, 2005), providing an argument to treat patients with lung cancer by an association of taxanes and anti-COX-2 drugs.